Lam Research
LRCX
$290.20
-3.74%
Lam Research Corp is a leading supplier of semiconductor wafer fabrication equipment, specializing in deposition and etch processes essential for manufacturing advanced chips. The company holds the top market share in etch and the clear second share in deposition, serving major customers like TSMC, Samsung, Intel, and Micron. The current investor narrative centers on the AI-driven semiconductor supercycle, with Lam positioned as a critical enabler of AI chip manufacturing, evidenced by record quarterly revenue and a bullish outlook. However, recent market volatility and concerns about overvaluation in AI-related sectors have introduced debate about the sustainability of its growth trajectory.…
LRCX
Lam Research
$290.20
Related headlines
Investment Opinion: Should I buy LRCX Today?
Based on the analysis, LRCX is rated a Buy. The company's strong revenue growth, high margins, and market leadership in etch and deposition position it well for the AI-driven semiconductor supercycle. The consensus rating is Strong Buy with an average target of $371.19, implying 22.9% upside. The thesis is supported by record Q3 revenue of $5.84B, 23.8% YoY growth, and a forward PE of 26.12x, which is reasonable given expected EPS growth.
Sign up to view all
LRCX 12-Month Price Forecast
The AI-driven semiconductor supercycle is a powerful tailwind for Lam Research, with record revenue and strong margins. However, the stock's high valuation and cyclicality introduce uncertainty. The stance is bullish given the fundamental momentum, but confidence is medium due to the risk of multiple compression. If revenue growth continues to accelerate and margins hold, the stock could re-rate higher; if AI demand falters, the downside could be significant. Monitoring quarterly earnings and industry capex trends will be crucial.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $371.19 and implied upside of +27.9% versus the current price.
Average Target
$371.19
0 analysts
Implied Upside
+27.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$290 - $500
Analyst target range
Lam Research is covered by 31 analysts, with a consensus recommendation of 'Strong Buy' (mean rating of 1.46 on a 1-5 scale). The average target price is $371.19, implying an upside of 22.9% from the current price of $301.90. The distribution of ratings is heavily skewed towards buy, with no sell ratings, indicating strong bullish sentiment. The target price range spans from a low of $290.00 to a high of $500.00, reflecting a wide dispersion in expectations. The high target of $500 suggests that some analysts anticipate continued strong growth and multiple expansion, possibly driven by AI-driven demand and Lam's market position. The low target of $290 implies a modest downside of -3.9%, likely accounting for potential cyclical downturns or competitive pressures. Recent institutional ratings have been consistently positive, with firms like Needham, Stifel, and Mizuho reiterating Buy or Outperform ratings in July 2026, reinforcing the bullish outlook. The wide range between the low and high targets indicates significant uncertainty about the pace of AI adoption and semiconductor cycle dynamics, but the overall consensus remains firmly optimistic.
Drowning in data?
Find the real signal!
Bulls vs Bears: LRCX Investment Factors
Lam Research presents a compelling growth story driven by AI demand, with record revenue, strong margins, and a bullish analyst consensus. However, the stock trades at historically high multiples, leaving it vulnerable to any disappointment. The bull case is supported by tangible fundamentals and market leadership, while the bear case hinges on valuation and cyclicality. Currently, the bull side has stronger evidence given the accelerating growth and analyst confidence, but the key tension is whether the market's high expectations can be met. If AI-driven demand continues to exceed forecasts, the stock could re-rate higher; if growth decelerates or the AI bubble bursts, the premium valuation could lead to significant downside.
Bullish
- Record Revenue Growth Accelerating: Q3 FY2026 revenue hit $5.84B, up 23.8% YoY, with sequential acceleration from 22.2% in Q2 and 28.0% in Q1. This demonstrates robust demand for AI-driven chip manufacturing equipment, positioning Lam as a key enabler of the AI supercycle.
- Strong Profitability and Margins: Net margin stands at 31.3% and operating margin at 35.3%, both well above industry averages. This high profitability supports premium valuation and provides a cushion against cyclical downturns.
- Analyst Consensus Strong Buy: 31 analysts rate LRCX a Strong Buy (mean 1.46), with an average target of $371.19, implying 22.9% upside. No sell ratings, and recent reiterations from Needham, Stifel, and Mizuho reinforce bullish sentiment.
- Market Leadership in Etch and Deposition: Lam holds the #1 share in etch and #2 in deposition, serving top customers like TSMC, Samsung, Intel, and Micron. This entrenched position provides pricing power and long-term growth visibility.
Bearish
- Extreme Valuation Premium: Trailing PE is 70.97x, far above the historical range of 8.9x-34.2x and a 223% premium to the industry average of 22x. This leaves little room for error; any earnings miss could trigger sharp multiple compression.
- High Beta Amplifies Market Volatility: With a beta of 1.865, LRCX is highly sensitive to market swings. The stock recently fell 16.7% from its 52-week high of $438.50, and a 41.76% max drawdown shows the potential for severe losses in downturns.
- Cyclicality of Semiconductor Industry: Semiconductor equipment spending is notoriously cyclical. Lam's revenue growth could decelerate sharply if memory chipmakers (DRAM/NAND) cut capex, as seen in past cycles. The current growth is partly driven by AI, which may be overhyped.
- Sell-the-News Risk in AI Sector: Recent news highlights a 'sell the news' event after Samsung's strong earnings, dragging down semiconductor stocks. This suggests the market may be pricing in overly optimistic AI expectations, leading to volatility and potential corrections.
LRCX Technical Analysis
Lam Research's stock has exhibited a powerful long-term uptrend, with a 1-year price change of +190.04%, significantly outperforming the S&P 500's +18.56% over the same period. The current price of $301.90 sits at 61.5% of the 52-week range (low: $94.11, high: $438.50), indicating a pullback from the highs but still well above the lows. This positioning suggests the stock is in a corrective phase within a broader bull market, offering potential value for investors who believe in the long-term AI growth story, though it also reflects the elevated volatility typical of high-beta tech names.
Beta
1.86
1.86x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$94-$439
Price range past year
Annual Return
+189.8%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | -1.0% | +2.0% |
| 3m | -15.6% | +1.0% |
| 6m | +35.2% | +11.8% |
| 1y | +189.8% | +18.1% |
| ytd | +56.8% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory is robustly growing, with the most recent quarter (Q3 FY2026, ending March 29, 2026) reporting revenue of $5.84 billion, a 23.76% year-over-year increase. This marks a continuation of an accelerating trend, as revenue has grown sequentially from $4.72 billion in Q3 FY2025 to $5.84 billion, with quarterly growth rates of 23.8% (Q3 FY2026), 22.2% (Q2 FY2026), and 28.0% (Q1 FY2026) compared to the prior year. The growth is driven by strong demand for AI-related chips, with system sales contributing $3.73 billion and customer support adding $2.11 billion, both segments expanding. This momentum underscores Lam's critical role in the semiconductor equipment industry, though investors should monitor for potential cyclicality in the semiconductor market.
Quarterly Revenue
$5.8B
2026-03
Revenue YoY Growth
+23.8%
YoY Comparison
Gross Margin
49.8%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Given Lam Research's positive net income, the PE ratio is the primary valuation metric. The trailing PE stands at 70.97x, while the forward PE is 26.12x, implying the market expects significant earnings growth. This gap suggests that investors are pricing in a substantial acceleration in profitability, likely driven by AI-driven demand for advanced chips. The PEG ratio of 1.83x indicates that the stock is not excessively overvalued relative to its expected growth, but it is not cheap either. Compared to the industry average PE of 22x (from valuation data), Lam trades at a 223% premium, reflecting its market leadership and growth prospects. However, this premium is justified by Lam's superior net margin of 31.27% and operating margin of 35.29%, which are well above industry norms. Historically, Lam's PE has ranged from 8.9x to 34.2x over the past few years, with the current trailing PE of 70.97x significantly above that range, indicating that the stock is trading at historically high multiples. This suggests that the market is pricing in optimistic expectations for future growth, and any disappointment could lead to multiple compression.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a high trailing PE of 70.97x, which implies that investors are paying a premium for future earnings. If growth decelerates, the stock could face multiple compression, as seen in the historical PE range of 8.9x-34.2x. The company's debt-to-equity ratio is 0.33, which is manageable, but the high payout ratio of 17.5% and dividend yield of 0.25% indicate limited income support. Free cash flow is strong at $6.45B TTM, but the reliance on continued revenue growth to justify valuation is a key risk.
